Clinical Trials Logo

Allergic Conjunctivitis clinical trials

View clinical trials related to Allergic Conjunctivitis.

Filter by:

NCT ID: NCT01363713 Completed - Clinical trials for Allergic Conjunctivitis

A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

Safety and efficacy of DE-114 ophthalmic solution will be evaluated in patients with allergic conjunctivitis, in an open-label, multicenter study.

NCT ID: NCT01363700 Completed - Clinical trials for Allergic Conjunctivitis

Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of the study is to demonstrate safety and efficacy of DE-114 ophthalmic solution compared to its Placebo and Olopatadine hydrochloride 0.1% ophthalmic solution in patients with allergic conjunctivitis.

NCT ID: NCT01346371 Completed - Clinical trials for Allergic Conjunctivitis

The Effect of BEPREVE 1.5% on Tear Film Osmolarity and Tear Film Lipid Layer

Start date: May 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effect of Bepreve® with an artificial-tear eye drop on the quality of your tears.

NCT ID: NCT01339507 Completed - Clinical trials for Allergic Conjunctivitis

A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft

Start date: April 2011
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the comfort of BEPREVE compared to LASTACAFT after instillation.

NCT ID: NCT01337557 Enrolling by invitation - Clinical trials for Allergic Conjunctivitis

Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses

Start date: May 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.

NCT ID: NCT01332188 Completed - Clinical trials for Allergic Conjunctivitis

Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model

AC-170
Start date: April 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of different concentrations of AC-170 compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in the conjunctival allergen challenge (CAC) Model.

NCT ID: NCT01326858 Completed - Clinical trials for Allergic Conjunctivitis

Safety and Comfort of AL-4943A Ophthalmic Solution

Start date: April 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the ocular comfort and safety of olopatadine hydrochloride opthalmic solution. 0.7%.

NCT ID: NCT01320553 Completed - Clinical trials for Allergic Conjunctivitis

Effect of Different Concentrations of 1334H on Allergic Conjunctivitis

Start date: June 2011
Phase: Phase 2
Study type: Interventional

The present study will test if administration of different concentrations of 1334H eyedrops will be effective in treatment of allergic conjunctivitis in people with 10 yrs of age or older.

NCT ID: NCT01294969 Completed - Clinical trials for Allergic Conjunctivitis

Patient Perception Study for AL-4943A

Start date: September 2010
Phase: Phase 4
Study type: Interventional

To evaluate patient perceptions of Al-4943 in subjects with allergic conjunctivitis previously treated with a topical ocular anti-allergy leukotriene-release inhibitor medication.

NCT ID: NCT01282138 Completed - Clinical trials for Allergic Conjunctivitis

Assessment of Alcon's Ocular Image Quantification System

Start date: December 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study was to evaluate ocular responses with different allergen provocation methods.